The performance of model-based versus rule-based phase I clinical trials in oncology E. M. J. van BrummelenA. D. R. HuitemaJ. H. M. Schellens Review Paper 10 March 2016 Pages: 235 - 242
Model-based pharmacokinetic analysis of elotuzumab in patients with relapsed/refractory multiple myeloma Leonid GibianskyChaitali PasseyManish Gupta Original Paper 18 March 2016 Pages: 243 - 257
Models for the red blood cell lifespan Rajiv P. ShresthaJoseph HorowitzYossi Chait Original Paper 02 April 2016 Pages: 259 - 274
Evaluation of estimation, prediction and inference for autocorrelated latent variable modeling of binary data—a simulation study Matthew M. Hutmacher Original Paper 23 March 2016 Pages: 275 - 289
Minimal physiologically-based pharmacokinetic (mPBPK) model for a monoclonal antibody against interleukin-6 in mice with collagen-induced arthritis Xi ChenXiling JiangWeirong Wang Original Paper 27 April 2016 Pages: 291 - 304
Approaches for modeling within subject variability in pharmacometric count data analysis: dynamic inter-occasion variability and stochastic differential equations Chenhui DengElodie L. PlanMats O. Karlsson Original Paper 10 May 2016 Pages: 305 - 314
The pharmacokinetics of dexmedetomidine during long-term infusion in critically ill pediatric patients. A Bayesian approach with informative priors Paweł WiczlingAlicja Bartkowska-ŚniatkowskaAgnieszka Bienert Original Paper Open access 24 May 2016 Pages: 315 - 324
Predicting the probability of successful efficacy of a dissociated agonist of the glucocorticoid receptor from dose–response analysis Daniela J. ConradoSriram KrishnaswamiBrinda K. Tammara Original Paper 13 May 2016 Pages: 325 - 341